Principal Investigator

Glenn J
Awardee Organization

Wake Forest University Health Sciences
United States

Fiscal Year
Activity Code
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Clinical Studies NCORP Boot Camp Program for Early-Career Investigators

Supplement: The Wake Forest NCI Community Oncology Research Program Research Base (WF NCORP) is committed to training the next generation of Cancer Control and Cancer Care Delivery Research (CCDR) investigators. WF NCORP MPIs (Lesser & Weaver) and leaders supported by this supplement (Dressler, Klepin, & Strom) are experienced research mentors, including mentoring experience with trainees traditionally under-represented in biomedical research. Through this supplement, our team will build on current mentoring activities in the parent award to expand mentoring opportunities for new NCORP investigators who are members of groups underrepresented in the biomedical research enterprise by adapting a successful Clinical Trials Boot Camp program developed by Dr. Dressler for the WF Comprehensive Cancer Center (WF CCC). The new NCORP Boot Camp program will facilitate the research success of participants by enhancing their access to mentoring, pilot grant funds, and grant writing skills, with the ultimate goal of enhancing the diversity, equity, inclusion, and accessibility (DEIA) of WF NCORP study PIs and the WF NCORP leadership pipeline.

Clinical Trials

Study Name Clinical Trial ID
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma NCT03475186
Work Ability in Young Adult Cancer Survivors NCT03148080
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil NCT02822573
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer NCT03963739
An Internet-based Program to Help Cancer Survivors Manage Pain NCT04462302
Stepped-Care Telehealth for Distress in Cancer Survivors NCT03060096
Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices NCT03746314
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy NCT05703269